ロード中...
Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes
This retrospective cohort study evaluated the risk of prostate cancer associated with sitagliptin use in Taiwanese male patients with type 2 diabetes mellitus by using the reimbursement databases of the National Health Insurance. Male patients with newly diagnosed type 2 diabetes mellitus at an age...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386669/ https://ncbi.nlm.nih.gov/pubmed/27661113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12137 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|